| 1 | ACP5, SPENCD1
|
| Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.
|
| Lausch E, Janecke A, Bros M, Trojandt S, Alanay Y, De Laet C, Hübner CA, Meinecke P, Nishimura G, Matsuo M, Hirano Y, Tenoutasse S, Kiss A, Rosa RF, Unger SL, Renella R, Bonafé L, Spranger J, Unger S, Zabel B, Superti-Furga A.
|
| Nat Genet 43(2):132-7. Epub 2011 Jan 9.
2011
|
| 2 | ACP5, NFATC1, OSCAR, TNFSF11
|
| RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation.
|
| Kim JH, Kim K, Youn BU, Jin HM, Kim JY, Moon JB, Ko A, Seo SB, Lee KY, Kim N.
|
| Biochem J 436(2):253-62.
2011
|
| 3 | ACP5, SPP1
|
| Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase.
|
| Ek-Rylander B, Andersson G.
|
| Exp Cell Res 316(3):443-51. Epub 2009 Oct 23.PMID: 19854170 2010
|
| 4 | ACP5, STAT6
|
| Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly.
|
| Yu M, Moreno JL, Stains JP, Keegan AD.
|
| J Biol Chem 284(47):32968-79. Epub 2009 Sep 28.PMID: 19801646 2009
|
| 5 | ACP5, PARP1
|
| Poly(adp-ribose) polymerase-1 regulates Tracp gene promoter activity during RANKL-induced osteoclastogenesis.
|
| Beranger GE, Momier D, Rochet N, Carle GF, Scimeca JC.
|
| J Bone Miner Res 23(4):564-71.PMID: 18021007 2008
|
| 6 | ACP5
|
| Significance of serum TRACP in rheumatoid arthritis.
|
| Janckila AJ, Neustadt DH, Yam LT.
|
| J Bone Miner Res 23(8):1287-95.PMID: 18410226 2008
|
| 7 | ACP5
|
| Altered collagen in tartrate-resistant acid phosphatase (TRAP)-deficient mice: a role for TRAP in bone collagen metabolism.
|
| Roberts HC, Knott L, Avery NC, Cox TM, Evans MJ, Hayman AR.
|
| Calcif Tissue Int 80(6):400-10. Epub 2007 Jun 7.PMID: 17551769 2007
|
| 8 | ACP5
|
| TRACP Influences Th1 pathways by affecting dendritic cell function.
|
| Esfandiari E, Bailey M, Stokes CR, Cox TM, Evans MJ, Hayman AR.
|
| J Bone Miner Res 21(9):1367-76.PMID: 16939395 2006
|
| 9 | ACP5
|
| Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma.
|
| Chan KY, Wong N, Lai PB, Squire JA, Macgregor PF, Beheshti B, Albert M, To KF, Johnson PJ.
|
| Int J Cancer 114(6):902-8. 2005
|
| 10 | ACP5
|
| TRACP as an osteopontin phosphatase.
|
| Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sjolander J, Lang P, Norgard M, Wang Y, Zhang SJ.
|
| J Bone Miner Res 18(10):1912-5. Review. 2003
|
| 11 | ACP5
|
| Structure of the gene for uteroferrin.
|
| Vallet JL, Fahrenkrug SC.
|
| DNA Cell Biol 19(11):689-96. 2000
|
| 12 | ACP5
|
| Cloning and characterization of the human tartrate-resistant acid phosphatase (TRAP) gene.
|
| Fleckenstein E, et al.
|
| Leukemia 10 : 637-643. 1996
|
| 13 | ACP5
|
| Confirmation of the assignment of the human tartrate-resistant acid phosphatase gene (ACP5) to chromosome 19.
|
| Leach RJ, et al.
|
| Genomics 19 : 180-181. 1994
|
| 14 | ACP5
|
| Type 5 acid phosphatase.
|
| Lord DK, et al.
|
| Eur J Biochem 189 : 287-293. 1990
|
| 15 | ACP5
|
| Localization of the human type 5, tartrate-resistant acid phosphatase gene by in situ hybridization.
|
| Allen BS, et al.
|
| Genomics 4 : 597-600. 1989
|